SEAMILD FOODS(SZ:002956) Huaxin Securities·2025-10-30 11:04Investment Rating - The report maintains a "Buy" investment rating for Ximai Food (002956.SZ) [8] Core Insights - The company's total operating revenue for Q1-Q3 2025 reached 1.696 billion yuan, representing an 18% year-on-year increase, while the net profit attributable to shareholders was 132 million yuan, up 22% year-on-year [1] - The gross profit margin for Q3 2025 increased by 1 percentage point to 43.75%, driven by product structure optimization and a decrease in raw material costs [2] - The launch of the medicinal food series in September received positive feedback, with a focus on market testing and consumer feedback collection in Q4 2025 [3] Financial Performance - For Q3 2025, total operating revenue was 547 million yuan, a 19% increase year-on-year, and the net profit attributable to shareholders was 51 million yuan, up 21% year-on-year [1] - The company has locked in raw material prices for the year, and costs are expected to continue declining, which will support sustained gross margin improvements [2] - The adjusted earnings per share (EPS) forecasts for 2025-2027 are 0.77, 1.02, and 1.27 yuan, respectively, with corresponding price-to-earnings (PE) ratios of 28, 21, and 17 times [8] Market Position and Strategy - Ximai Food is focusing on the oat category, with a strong emphasis on the health strategy, which is progressing smoothly [4] - The online sales channel continues to show rapid growth while maintaining cost control, and the company is expected to improve channel profitability further [3] - The company is adapting its product offerings in response to market conditions, including the introduction of new high-protein oat products in various retail channels [3]